Scarica l'app Stockscreener
2.50
4.60%
0.11
Vyne Therapeutics Inc Azioni (VYNE) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
28.95%
0.098
|
0.076 | 0.114 | 0.135 | 0.099 |
Operating Expenses
|
8.25%
7.478
|
6.908 | 6.348 | 10.45 | 5.974 |
| Benefits Costs and Expenses |
1.78%
6.339
|
6.228 | 6.185 | 10.17 | 5.711 |
| Costs And Expenses |
8.25%
7.478
|
6.908 | 6.348 | 10.45 | 5.974 |
| Operating Income/Loss |
8.02%
-7.38
|
-6.832 | -6.234 | -10.32 | -5.875 |
| Income/Loss From Continuing Operations Before Tax |
1.45%
-6.241
|
-6.152 | -6.071 | -10.04 | -5.612 |
| Income Tax Expense/Benefit |
-
|
- | - | - | - |
| Income/Loss From Continuing Operations After Tax |
1.45%
-6.241
|
-6.152 | -6.071 | -10.04 | -5.612 |
| Income/Loss From Discontinued Operations, Net Of Tax |
77.78%
-0.008
|
-0.036 | -0.513 | -0.02 | -0.01 |
|
Net Income/Loss
|
0.99%
-6.249
|
-6.188 | -6.584 | -10.06 | -5.622 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
508.13%
42.58
|
7.002 | 3.282 | 3.274 | 3.255 |
| Diluted Average Shares |
508.13%
42.58
|
7.002 | 3.282 | 3.274 | 3.255 |
| Basic Earnings Per Share |
103.71%
-0.15
|
4.04 | -2.01 | -3.09 | -1.74 |
| Diluted Earnings Per Share |
103.71%
-0.15
|
4.04 | -2.01 | -3.09 | -1.74 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
2.88%
2.65%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):